1. Home
  2. KLXE vs UNCY Comparison

KLXE vs UNCY Comparison

Compare KLXE & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

N/A

Current Price

$1.02

Market Cap

106.1M

Sector

Energy

ML Signal

N/A

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

N/A

Current Price

$3.53

Market Cap

100.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLXE
UNCY
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.1M
100.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
KLXE
UNCY
Price
$1.02
$3.53
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $28.40
AVG Volume (30 Days)
352.6K
★ 1.1M
Earning Date
11-05-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $636,600,000.00
$675,000.00
Revenue This Year
$4.43
N/A
Revenue Next Year
$8.47
$10,044.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.96
$3.33
52 Week High
$4.50
$8.74

Technical Indicators

Market Signals
Indicator
KLXE
UNCY
Relative Strength Index (RSI) 32.51 39.82
Support Level N/A $3.35
Resistance Level $1.23 $4.18
Average True Range (ATR) 0.10 0.25
MACD -0.01 0.03
Stochastic Oscillator 23.37 24.71

Price Performance

Historical Comparison
KLXE
UNCY

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: